Rudd International Inc. bought a new stake in Baxter International Inc (NYSE:BAX) in the 2nd quarter, Holdings Channel.com reports. The fund bought 2,785 shares of the medical instruments supplier’s stock, valued at approximately $228,000.

A number of other institutional investors have also added to or reduced their stakes in BAX. GHP Investment Advisors Inc. grew its position in Baxter International by 2.1% during the second quarter. GHP Investment Advisors Inc. now owns 13,327 shares of the medical instruments supplier’s stock valued at $1,091,000 after acquiring an additional 269 shares during the period. Employers Holdings Inc. purchased a new stake in Baxter International during the second quarter valued at about $262,000. Wealth Enhancement Advisory Services LLC purchased a new stake in Baxter International during the second quarter valued at about $1,887,000. Candriam Luxembourg S.C.A. grew its position in Baxter International by 51.4% during the second quarter. Candriam Luxembourg S.C.A. now owns 74,046 shares of the medical instruments supplier’s stock valued at $7,674,000 after acquiring an additional 25,154 shares during the period. Finally, FinTrust Capital Advisors LLC grew its position in Baxter International by 97.2% during the second quarter. FinTrust Capital Advisors LLC now owns 3,029 shares of the medical instruments supplier’s stock valued at $248,000 after acquiring an additional 1,493 shares during the period. Hedge funds and other institutional investors own 83.96% of the company’s stock.

A number of equities research analysts have issued reports on the company. Barclays set a $82.00 price target on Baxter International and gave the company a “hold” rating in a research report on Friday, July 26th. Credit Suisse Group boosted their price target on Baxter International from $84.00 to $95.00 and gave the company an “outperform” rating in a research report on Friday, July 26th. KeyCorp assumed coverage on Baxter International in a research report on Tuesday, June 25th. They set a “sector weight” rating for the company. Piper Jaffray Companies boosted their price target on Baxter International from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, July 25th. Finally, JPMorgan Chase & Co. boosted their price target on Baxter International from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Monday, May 13th. Four research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $85.27.

In related news, SVP Jacqueline Kunzler sold 593 shares of the stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $80.46, for a total value of $47,712.78. Following the completion of the transaction, the senior vice president now owns 9,023 shares of the company’s stock, valued at $725,990.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John D. Forsyth sold 1,320 shares of the stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $78.21, for a total value of $103,237.20. Following the completion of the transaction, the director now directly owns 32,779 shares of the company’s stock, valued at approximately $2,563,645.59. The disclosure for this sale can be found here. 0.70% of the stock is owned by corporate insiders.

Shares of NYSE BAX traded up $1.19 on Friday, hitting $86.97. The company had a trading volume of 1,573,500 shares, compared to its average volume of 2,396,134. Baxter International Inc has a 12-month low of $61.05 and a 12-month high of $88.28. The business has a 50 day moving average of $83.63 and a two-hundred day moving average of $78.28. The company has a quick ratio of 2.10, a current ratio of 2.78 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $43.80 billion, a P/E ratio of 28.51, a PEG ratio of 1.99 and a beta of 1.00.

Baxter International (NYSE:BAX) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.89 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.08. Baxter International had a return on equity of 21.21% and a net margin of 14.28%. The company had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.80 billion. During the same quarter in the prior year, the business earned $0.77 earnings per share. The company’s revenue was down .1% compared to the same quarter last year. On average, sell-side analysts anticipate that Baxter International Inc will post 3.37 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th will be given a $0.22 dividend. This represents a $0.88 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Thursday, August 29th. Baxter International’s payout ratio is 28.85%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

See Also: Understanding Analyst Recommendations

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.